Efficacy of Oral Ribavirin in Lung Transplant Patients With Respiratory Syncytial Virus Lower Respiratory Tract Infection

BACKGROUND: Respiratory syncytial virus (RSV) can cause severe lower respiratory tract infection (LRI) and is a risk factor for the development of bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx). Currently, the most widely used therapy for RSV is inhaled ribavirin. However,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Pelaez, Andres, Lyon, G. Marshall, Force, Seth D., Ramirez, Allan M., Neujahr, David C., Foster, Marianne, Naik, Priyumvada M., Gal, Anthony A., Mitchell, Patrick O., Lawrence, E. Clinton
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3395057/
https://ncbi.nlm.nih.gov/pubmed/19134533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.healun.2008.10.008
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars